These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 8923123)

  • 1. Pharmacokinetics of milnacipran in comparison with other antidepressants.
    Puozzo C; Leonard BE
    Int Clin Psychopharmacol; 1996 Sep; 11 Suppl 4():15-27. PubMed ID: 8923123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacokinetics and drug interactions of antidepressive agents].
    Sawada Y; Ohtani H
    Nihon Rinsho; 2001 Aug; 59(8):1539-45. PubMed ID: 11519155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of the newer antidepressants. An overview of the pharmacological and pharmacokinetic implications.
    Caccia S
    Clin Pharmacokinet; 1998 Apr; 34(4):281-302. PubMed ID: 9571301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacokinetics and drug interaction of antidepressants and anti-manic drugs].
    Suzuki K; Koyama T
    Ryoikibetsu Shokogun Shirizu; 2003; (38):366-9. PubMed ID: 12877004
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacology and pharmacokinetics of milnacipran.
    Puozzo C; Panconi E; Deprez D
    Int Clin Psychopharmacol; 2002 Jun; 17 Suppl 1():S25-35. PubMed ID: 12369608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: an update.
    Spina E; Santoro V; D'Arrigo C
    Clin Ther; 2008 Jul; 30(7):1206-27. PubMed ID: 18691982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Milnacipran: beyond a role of antidepressant.
    Pae CU; Marks DM; Shah M; Han C; Ham BJ; Patkar AA; Masand PS
    Clin Neuropharmacol; 2009; 32(6):355-63. PubMed ID: 19620845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonin and Norepinephrine Reuptake Inhibitors.
    Shelton RC
    Handb Exp Pharmacol; 2019; 250():145-180. PubMed ID: 30838456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Milnacipran and selective serotonin reuptake inhibitors in major depression.
    Lopez-Ibor J; Guelfi JD; Pletan Y; Tournoux A; Prost JF
    Int Clin Psychopharmacol; 1996 Sep; 11 Suppl 4():41-6. PubMed ID: 8923126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Milnacipran, a new specific serotonin and noradrenaline reuptake inhibitor.
    Boyer P; Briley M
    Drugs Today (Barc); 1998 Aug; 34(8):709-20. PubMed ID: 14988777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical pharmacology of milnacipran.
    Briley M; Prost JF; Moret C
    Int Clin Psychopharmacol; 1996 Sep; 11 Suppl 4():9-14. PubMed ID: 8923122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Milnacipran, a new serotonin and noradrenaline reuptake inhibitor: an overview of its antidepressant activity and clinical tolerability.
    Puech A; Montgomery SA; Prost JF; Solles A; Briley M
    Int Clin Psychopharmacol; 1997 Mar; 12(2):99-108. PubMed ID: 9219045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic effects of antidepressants on serotonin release in rat raphe slice cultures: high potency of milnacipran in the augmentation of serotonin release.
    Nagayasu K; Kitaichi M; Nishitani N; Asaoka N; Shirakawa H; Nakagawa T; Kaneko S
    Int J Neuropsychopharmacol; 2013 Nov; 16(10):2295-306. PubMed ID: 23920436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerability of milnacipran: an overview.
    Montgomery SA; Prost JF; Solles A; Briley M
    Int Clin Psychopharmacol; 1996 Sep; 11 Suppl 4():47-51. PubMed ID: 8923127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excretion and metabolism of milnacipran in humans after oral administration of milnacipran hydrochloride.
    Li F; Chin C; Wangsa J; Ho J
    Drug Metab Dispos; 2012 Sep; 40(9):1723-35. PubMed ID: 22653299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative studies with milnacipran and tricyclic antidepressants in the treatment of patients with major depression: a summary of clinical trial results.
    Kasper S; Pletan Y; Solles A; Tournoux A
    Int Clin Psychopharmacol; 1996 Sep; 11 Suppl 4():35-9. PubMed ID: 8923125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Milnacipran: a comparative analysis of human monoamine uptake and transporter binding affinity.
    Vaishnavi SN; Nemeroff CB; Plott SJ; Rao SG; Kranzler J; Owens MJ
    Biol Psychiatry; 2004 Feb; 55(3):320-2. PubMed ID: 14744476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of interaction of milnacipran with the cytochrome p450 isoenzymes frequently involved in the metabolism of antidepressants.
    Puozzo C; Lens S; Reh C; Michaelis K; Rosillon D; Deroubaix X; Deprez D
    Clin Pharmacokinet; 2005; 44(9):977-88. PubMed ID: 16122284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serotonin-noradrenaline reuptake inhibitors(SNRIs)].
    Ishigooka J
    Nihon Rinsho; 2001 Aug; 59(8):1523-9. PubMed ID: 11519152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological principles of antidepressant efficacy.
    Schatzberg AF
    Hum Psychopharmacol; 2002 Jun; 17 Suppl 1():S17-22. PubMed ID: 12404665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.